Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Antonio Lewis Camargo"'
Autor:
Mileydis Alonso, Radhika K. Neicheril, Yosef Manla, Malcolm L. McDonald, Alejandro Sanchez, Gabrielle Lafave, Yelenis Seijo De Armas, Antonio Lewis Camargo, Dipan Uppal, David Wolinsky, Nina Thakkar‐Rivera, Mauricio Velez, David A. Baran, Jerry D. Estep, David Snipelisky
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 3649-3655 (2024)
Abstract Aims Transthyretin cardiac amyloidosis (ATTR‐CA) is most often associated with heart failure with preserved ejection fraction (HFpEF). However, patients may present with impaired systolic function at the time of diagnosis, which has not be
Externí odkaz:
https://doaj.org/article/12457931b31f4a85b2136c051a49736a
Autor:
Richard B. Aguilar, Patrick Hardigan, Bindu Mayi, Darby Sider, Jared Piotrkowski, Jinesh P. Mehta, Jenankan Dev, Yelenis Seijo, Antonio Lewis Camargo, Luis Andux, Kathleen Hagen, Marlow B. Hernandez
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Importance: Currently, there is no unified framework linking disease progression to established viral levels, clinical tests, inflammatory markers, and investigational treatment options.Objective: It may take many weeks or months to establish a stand
Externí odkaz:
https://doaj.org/article/d467be99cb2e423f81b6348fe05e8753
Autor:
Jinesh Mehta, Luis Andux, Antonio Lewis Camargo, Richard B. Aguilar, Jenankan Dev, Darby Sider, Kathleen Hagen, Marlow B. Hernandez, Jared Piotrkowski, Yelenis Seijo, Patrick C. Hardigan, Bindu S. Mayi
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Frontiers in Medicine
ImportanceCurrently, there is no unified framework linking disease progression to established viral levels, clinical tests, inflammatory markers, and investigational treatment options.ObjectiveIt may take many weeks or months to establish a standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e686fcbf4fcdd36a8ebffa8c6dd5f14b
https://doi.org/10.1101/2020.04.19.20071548
https://doi.org/10.1101/2020.04.19.20071548
Autor:
Kevin Leung, Antonio Lewis Camargo, Elizabeth Blessing Elimimian, Charles Szuchan, Leah Elson, Diego Sadler, Evan W. Alley, Zeina Nahleh
Publikováno v:
European Heart Journal: Case Reports
Background Pembrolizumab, an immune checkpoint inhibitor (ICI), is an IgG4 antibody that blocks interaction between programmed cell death protein 1 and programmed death-ligand 1. Myocarditis, an immune-related adverse event, has been reported in thym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3aee7bc6b317a34cc75677480cb0c97
https://pubmed.ncbi.nlm.nih.gov/32617460
https://pubmed.ncbi.nlm.nih.gov/32617460
Autor:
Kevin S. Stadtlander, Luis Alonso Hernandez Mejia, Nicholas Ghiloni, Marcelo E. Helguera, Armin Shivazad, Hardik M. Bhansali, Sergio L. Pinski, Eduardo Perez, Nader Hanna, Jose L. Baez-Escudero, Diana Miranda Ruiz, Elsy Navas, Jose Sleiman, Roberto J. Cubeddu, Antonio Lewis Camargo, Kevin Leung
Publikováno v:
Journal of the American College of Cardiology. 75:2629
Tricuspid valve (TV) endocarditis presenting as a pulmonary artery (PA) septic embolism is a rare but frequently fatal complication. Most septic pulmonary embolism (PE) occlude segmental or subsegmental PA. Large central septic PE is rare with only 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::088aae96d9a99cdf1af879ff1b07eb00
https://doi.org/10.1016/s0735-1097(20)33256-3
https://doi.org/10.1016/s0735-1097(20)33256-3